Changes in LDL-C levels among primary health care patients with hypertension, coronary artery disease, and diabetes during a 36-month follow-up

Petra Valkonen, Ulla Mikkonen, Hannu Kautiainen, Pekka Mäntyselkä, Nina Tusa · 2026

Read Changes in LDL-C levels among primary health care patients with hypertension, coronary artery disease, and diabetes during a 36-month follow-up by Petra Valkonen, Ulla Mikkonen, Hannu Kautiainen, Pekka Mäntyselkä, Nina Tusa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13580365.txt.

Description

Petra Valkonen and co-authors follow cholesterol care in Finnish primary care over three years, in a 2026 study. LDL cholesterol is a top lever against heart disease. Patients with high blood pressure, heart artery disease, or diabetes stand to gain most from lowering it. The team sorted 507 such patients at one health center by their starting LDL level, matched to risk bands in the national guide.

The patients averaged 69 years of age. Those who started lowest were older, with lower blood pressure and less drinking. Drug choices shifted across all groups as the years passed, with two statins doing most of the work. The highest group cut its LDL by about a fifth over the follow-up, the biggest drop of all. Still, most groups ended short of the guide's targets. The authors call the gap the next task for everyday care.

Catalog record

CREATORPetra Valkonen, Ulla Mikkonen, Hannu Kautiainen, Pekka Mäntyselkä, Nina Tusa
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13580365

Browse the full library · About the Tower of Babel